Cargando…
Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling
RIPK2 mediates inflammatory signaling by the bacteria‐sensing receptors NOD1 and NOD2. Kinase inhibitors targeting RIPK2 are a proposed strategy to ameliorate NOD‐mediated pathologies. Here, we reveal that RIPK2 kinase activity is dispensable for NOD2 inflammatory signaling and show that RIPK2 inhib...
Autores principales: | Hrdinka, Matous, Schlicher, Lisa, Dai, Bing, Pinkas, Daniel M, Bufton, Joshua C, Picaud, Sarah, Ward, Jennifer A, Rogers, Catherine, Suebsuwong, Chalada, Nikhar, Sameer, Cuny, Gregory D, Huber, Kilian VM, Filippakopoulos, Panagis, Bullock, Alex N, Degterev, Alexei, Gyrd‐Hansen, Mads |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120666/ https://www.ncbi.nlm.nih.gov/pubmed/30026309 http://dx.doi.org/10.15252/embj.201899372 |
Ejemplares similares
-
Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors
por: Canning, Peter, et al.
Publicado: (2015) -
Activation loop targeting strategy for design of receptor-interacting protein kinase 2 (RIPK2) inhibitors
por: Suebsuwong, Chalada, et al.
Publicado: (2018) -
Targeting RIPK1,2,3 to combat inflammation
por: Bullock, Alex N., et al.
Publicado: (2015) -
SPOTing Acetyl-Lysine Dependent Interactions
por: Picaud, Sarah, et al.
Publicado: (2015) -
Structural Basis for Recruitment of DAPK1 to the KLHL20 E3 Ligase
por: Chen, Zhuoyao, et al.
Publicado: (2019)